Healthcare provider profile · identity verified

James Denzil Frederick, MD

Allopathic & Osteopathic Physicians|Family Medicine · WEST LIBERTY, KY · NPI 1881798502

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show James Denzil Frederick, MD received $63.41 in general payments during 2025 across 3 reported records.

ABBVIE INC. accounted for 76.8% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 3 associated products.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 26 claims for Linzess by this doctor in 2024.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 34 claims for Synthroid by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$63.41

3 reported records · 2 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
ABBVIE INC.	Unresolved — no canonical attribution shown	$48.67	76.8%	2	2025
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	Unresolved — no canonical attribution shown	$14.74	23.2%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$63.41	3

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
QULIPTA Normalized: qulipta	Drug	ABBVIE INC.	$48.67	2	2025
Source payment records 2025-02-25 · ABBVIE INC. · $16.82 · Open Payments source 2025-04-28 · ABBVIE INC. · $31.85 · Open Payments source
UBRELVY Normalized: ubrelvy	Drug	ABBVIE INC.	$48.67	2	2025
Source payment records 2025-02-25 · ABBVIE INC. · $16.82 · Open Payments source 2025-04-28 · ABBVIE INC. · $31.85 · Open Payments source
CAPLYTA Normalized: caplyta	Drug	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$14.74	1	2025
Source payment records 2025-10-14 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $14.74 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	LINZESS open payments reported associated product	CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608	Linzess · 2024 Exact normalized brand match · 1 Part D row	26	suppressed by CMS
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	SYNTHROID open payments reported associated product	CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636	Synthroid · 2024 Exact normalized brand match · 1 Part D row	34	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	736	164
Gabapentin	Gabapentin	715	121
Lisinopril	Lisinopril	698	139
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	586	17
Omeprazole	Omeprazole	565	135
Levothyroxine Sodium	Levothyroxine Sodium	486	104
Metformin Hcl	Metformin Hcl	479	105
Furosemide	Furosemide	441	96
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	435	91
Amlodipine Besylate	Amlodipine Besylate	432	90
Pantoprazole Sodium	Pantoprazole Sodium	427	93
Metoprolol Tartrate	Metoprolol Tartrate	411	93
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	374	82
Citalopram Hbr	Citalopram Hydrobromide	337	64
Trazodone Hcl	Trazodone Hcl	303	57
Losartan Potassium	Losartan Potassium	290	71
Duloxetine Hcl	Duloxetine Hcl	286	54
Rosuvastatin Calcium	Rosuvastatin Calcium	274	65
Metoprolol Succinate	Metoprolol Succinate	261	49
Albuterol Sulfate Hfa	Albuterol Sulfate	254	70
Farxiga	Dapagliflozin Propanediol	238	46
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	235	53
Labetalol Hcl	Labetalol Hcl	233	47
Clopidogrel	Clopidogrel Bisulfate	231	47
Tramadol Hcl	Tramadol Hcl	221	44
Azithromycin	Azithromycin	195	149
Tamsulosin Hcl	Tamsulosin Hcl	188	35
Jardiance	Empagliflozin	185	29
Alprazolam	Alprazolam	184	38
Famotidine	Famotidine	183	43
Potassium Chloride	Potassium Chloride	183	45
Carvedilol	Carvedilol	181	52
Eliquis	Apixaban	165	35
Hydrochlorothiazide	Hydrochlorothiazide	162	39
Pravastatin Sodium	Pravastatin Sodium	161	37
Doxycycline Hyclate	Doxycycline Hyclate	157	66
Glipizide	Glipizide	155	38
Tradjenta	Linagliptin	154	28
Januvia	Sitagliptin Phosphate	152	28
Lorazepam	Lorazepam	147	24
Ondansetron Hcl	Ondansetron Hcl	138	47
Ibuprofen	Ibuprofen	134	43
Amitriptyline Hcl	Amitriptyline Hcl	128	36
Esomeprazole Magnesium	Esomeprazole Magnesium	124	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	121	24
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	117	26
Warfarin Sodium	Warfarin Sodium	113	15
Pregabalin	Pregabalin	109	23
Fluticasone Propionate	Fluticasone Propionate	104	51
Sertraline Hcl	Sertraline Hcl	104	18
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	99	76
Simvastatin	Simvastatin	99	22
Fluconazole	Fluconazole	93	47
Meloxicam	Meloxicam	92	28
Prednisone	Prednisone	91	49
Baclofen	Baclofen	89	30
Ropinirole Hcl	Ropinirole Hcl	89	15
Metformin Hcl Er	Metformin Hcl	84	17
Zolpidem Tartrate	Zolpidem Tartrate	84	19
Isosorbide Mononitrate Er	Isosorbide Mononitrate	83	18
Montelukast Sodium	Montelukast Sodium	82	21
Donepezil Hcl	Donepezil Hcl	81	23
Memantine Hcl	Memantine Hcl	81	14
Fenofibrate	Fenofibrate Nanocrystallized	80	19
Methylprednisolone	Methylprednisolone	80	68
Nifedipine Er	Nifedipine	80	26
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	80	18
Glipizide Er	Glipizide	78	16
Levofloxacin	Levofloxacin	78	64
Hydroxyzine Pamoate	Hydroxyzine Pamoate	77	16
Bupropion Xl	Bupropion Hcl	76	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	75	18
Aripiprazole	Aripiprazole	73	17
Mirtazapine	Mirtazapine	72	16
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	71	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	68	15
Ozempic	Semaglutide	68	16
Spironolactone	Spironolactone	68	14
Quetiapine Fumarate	Quetiapine Fumarate	67	16
Temazepam	Temazepam	67	19
Cefdinir	Cefdinir	65	56
Fluoxetine Hcl	Fluoxetine Hcl	65	13
Hydroxyzine Hcl	Hydroxyzine Hcl	65	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	63	19
Topiramate	Topiramate	62	18
Ventolin Hfa	Albuterol Sulfate	58	18
Paroxetine Hcl	Paroxetine Hcl	57	suppressed
Buspirone Hcl	Buspirone Hcl	56	14
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	55	36
Atenolol	Atenolol	54	12
Nystatin	Nystatin	54	20
Testosterone Cypionate	Testosterone Cypionate	54	suppressed
Xarelto	Rivaroxaban	53	11
Meclizine Hcl	Meclizine Hcl	49	18
Triamcinolone Acetonide	Triamcinolone Acetonide	48	27
Oxybutynin Chloride Er	Oxybutynin Chloride	47	suppressed
Naproxen	Naproxen	46	16
Finasteride	Finasteride	45	11
Fenofibrate	Fenofibrate	44	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	44	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	44	17
Cephalexin	Cephalexin	43	35
Clonidine Hcl	Clonidine Hcl	43	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	42	suppressed
Olanzapine	Olanzapine	42	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	41	suppressed
Entresto	Sacubitril/Valsartan	40	suppressed
Methocarbamol	Methocarbamol	40	suppressed
Tizanidine Hcl	Tizanidine Hcl	40	suppressed
Clarithromycin	Clarithromycin	38	35
Lansoprazole	Lansoprazole	37	suppressed
Amoxicillin	Amoxicillin	35	22
Synthroid	Levothyroxine Sodium	34	suppressed
Allopurinol	Allopurinol	33	12
Dicyclomine Hcl	Dicyclomine Hcl	33	suppressed
Levetiracetam	Levetiracetam	33	suppressed
Nitroglycerin	Nitroglycerin	33	17
Ondansetron Odt	Ondansetron	33	20
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Ezetimibe	Ezetimibe	31	suppressed
Varenicline Tartrate	Varenicline Tartrate	31	11
Bumetanide	Bumetanide	30	suppressed
Chlorthalidone	Chlorthalidone	30	suppressed
Hydralazine Hcl	Hydralazine Hcl	29	suppressed
Promethazine Hcl	Promethazine Hcl	29	13
Mupirocin	Mupirocin	28	26
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	27	19
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	27	suppressed
Amiodarone Hcl	Amiodarone Hcl	26	suppressed
Clindamycin Hcl	Clindamycin Hcl	26	22
Estradiol	Estradiol	26	suppressed
Linzess	Linaclotide	26	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	26	suppressed
Primidone	Primidone	26	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	25	suppressed
Trulicity	Dulaglutide	25	suppressed
Brilinta	Ticagrelor	23	suppressed
Theophylline Er	Theophylline Anhydrous	23	suppressed
Febuxostat	Febuxostat	22	suppressed
Celecoxib	Celecoxib	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	12
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	21	suppressed
Clonazepam	Clonazepam	20	suppressed
Ofloxacin	Ofloxacin	20	17
Propranolol Hcl	Propranolol Hcl	20	suppressed
Valsartan	Valsartan	20	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	19	suppressed
Glimepiride	Glimepiride	19	suppressed
Penicillin V Potassium	Penicillin V Potassium	19	13
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Mometasone Furoate	Mometasone Furoate	18	12
Mounjaro	Tirzepatide	18	suppressed
Ranolazine Er	Ranolazine	17	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Dexlansoprazole Dr	Dexlansoprazole	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	16	suppressed
Easy Touch Pen Needle	Pen Needle, Diabetic	15	suppressed
Ibandronate Sodium	Ibandronate Sodium	15	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Roflumilast	Roflumilast	15	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	14	suppressed
Dofetilide	Dofetilide	14	suppressed
Haloperidol	Haloperidol	14	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	14	suppressed
Kerendia	Finerenone	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Permethrin	Permethrin	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Flecainide Acetate	Flecainide Acetate	13	suppressed
Indomethacin	Indomethacin	13	suppressed
Loperamide	Loperamide Hcl	13	suppressed
Potassium Citrate Er	Potassium Citrate	13	suppressed
Sodium Chloride	0.9 % Sodium Chloride	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Benztropine Mesylate	Benztropine Mesylate	12	suppressed
Comfort Ez Insulin Syringe	Syringe And Needle,insulin,1ml	12	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	12	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	12	suppressed
Diazepam	Diazepam	12	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	12	suppressed
Lactulose	Lactulose	12	suppressed
Np Thyroid	Thyroid,pork	12	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	12	suppressed
Ssd	Silver Sulfadiazine	12	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	12	suppressed
Triazolam	Triazolam	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Verapamil Hcl	Verapamil Hcl	12	suppressed
Alendronate Sodium	Alendronate Sodium	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Cefprozil	Cefprozil	11	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Mono-Linyah	Norgestimate-Ethinyl Estradiol	11	suppressed
Raloxifene Hcl	Raloxifene Hcl	11	suppressed
Trokendi Xr	Topiramate	11	suppressed
Victoza 3-Pak	Liraglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$63.41 · 3 records	ABBVIE INC.	CAPLYTA, QULIPTA, UBRELVY	2	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error